By-health(300146)2025-01-24 10:18Financial Performance Expectations - The company expects a net profit attributable to shareholders of between 55 million and 78 million yuan for the year 2024, representing a decrease of 55.33% to 68.51% compared to the previous year[3]. - The net profit excluding non-recurring gains and losses is projected to be between 50 million and 75 million yuan, reflecting a decline of 53.04% to 68.69% year-over-year[3]. - The company reported non-recurring gains and losses of 149.37 million yuan for 2023, with an expected range of 30 million to 50 million yuan for 2024[5]. - The financial data in the earnings forecast has not been audited by a registered accountant[4]. - The earnings forecast is based on preliminary calculations by the company's finance department and will be detailed in the 2024 annual report[6]. Strategic Focus and Challenges - The company is focusing on a "scientific nutrition" strategy and product innovation to enhance consumer health value, amidst a changing consumption environment and intensified industry competition[5]. - The progress of upgrading two core products has been slower than originally planned, contributing to a significant decline in revenue and profit compared to the previous year[5]. Legal and Regulatory Considerations - The company has ongoing litigation matters that may impact future profits, with uncertain effects on the current and subsequent periods[6].